AtorvastatinLactamImpurity;1H-Pyrrole-1-heptanoicacid,5-(4-fluorophenyl)-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-4-phenyl-3-[(phenylamino)carbonyl]-,(βR,δR)-;(3R,5R)-7-(5-(4-fluorophChemicalbookenyl)-3-isopropyl-2-oxo-4-phenyl-3-(phenylcarbamoyl)-2,3-dihydro-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoicacid;AtorvastatinAcid-ImpurityQ;AtorvastatinImpurity27Monomer;Atorvastatincalciumimpurity9
Atorvastatin Impurity refers to synthetic by-products or degradation compounds associated with the active pharmaceutical ingredient atorvastatin. These impurities arise during manufacturing processes or storage and are strictly monitored to ensure drug safety.
Store in sealed containers at 2-8°C away from light. Personnel must wear PPE to prevent inhalation or skin contact, as some variants may exhibit cytotoxicity.